Market Overview:
The global endovenous ablation devices market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of venous diseases, technological advancements in endovenous ablation devices, and rising demand for minimally invasive procedures. Based on type, the global endovenous ablation devices market is segmented into EVLT devices, RFA devices, and NTNT devices. The EVLT device segment is expected to account for the largest share of the global endovenous ablation devices market in 2018. This segment is projected to grow at a CAGR of 7.8% from 2018 to 2030 due to its high adoption rate and growing demand for minimally invasive procedures.
Product Definition:
Endovenous ablation devices are medical devices used to remove blood from a vein. They are inserted into a vein through a small incision and used to suck out the blood. This is done as an alternative to surgery, which is often used to remove blood from veins.
EVLT devices:
Endovenous Laser Treatment (EVLT) is a minimally invasive procedure used to treat varicose veins, spider veins, and chronic venous insufficiency. It involves the use of laser energy to destroy the lining of the vein which causes bleeding and eventually leads to an empty tract.
RFA devices:
RFA devices are used for the treatment of patients suffering from chronic and acute pain, neuropathic pain, cancer-related pain, failed back syndrome and radiculopathies. RFA is also useful in treating peripheral nerve disorders such as carpal tunnel syndrome and mononeuropathy.
Application Insights:
Based on application, the global endovenous ablation devices market is segmented into hospital, clinic, research institute and others. The hospital segment dominated the market in 2017 owing to increasing prevalence of chronic diseases such as diabetes and high number of geriatric population that suffer from complications due to improper blood flow through veins. Thus, they opt for EDA procedures at hospitals as it offers effective treatment with lesser risk of complications compared to other settings.
The research institutes are anticipated to be fastest-growing application over the forecast period due to rising funding by governments for innovative medical treatments and EVAD being a cost-effective alternative for treating life-threatening conditions such as deep vein thrombosis (DVT) & pulmonary hypertension without mechanical ventilation. Moreover, growing awareness about EDA among healthcare professionals coupled with rising approval by regulatory authorities regarding use of these devices in clinical trials will further boost growth over the forecast period.
Regional Analysis:
North America dominated the global endovenous ablation devices market in 2017. This can be attributed to favorable reimbursement policies, high patient awareness levels coupled with relatively higher healthcare expenditure levels in this region as compared to other regions. The U.S is one of the most lucrative markets for medical device manufacturers due to its well-established healthcare infrastructure and advanced technology base pertaining to medical products penetration.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to increasing government initiatives and improving healthcare infrastructure especially in developing countries such as China & India which has resulted into increased adoption of technologically advanced EVLT systems that are both cost-effective.
Growth Factors:
- Increasing incidence of venous diseases: The incidence of venous diseases is increasing globally due to the changing lifestyle and growing population. This is expected to drive the demand for endovenous ablation devices in the coming years.
- Technological advancements: The technology for endovenous ablation devices is constantly evolving, which is resulting in better and more efficient devices being developed. This is likely to fuel the growth of this market in the near future.
- Growing awareness about venous diseases: There has been a growing awareness about venous diseases in recent years, owing to which patients are increasingly opting for treatment options such as endovenous ablation devices. This will help boost the demand for these devices in the coming years.
Scope Of The Report
Report Attributes
Report Details
Report Title
Endovenous Ablation Devices Market Research Report
By Type
EVLT devices, RFA devices, NTNT devices
By Application
Hospital, Research institute, Clinic, Other
By Companies
AngioDynamics Inc., Medtronic Plc, Sciton Inc., Teleflex Inc., Venclose Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Endovenous Ablation Devices Market Report Segments:
The global Endovenous Ablation Devices market is segmented on the basis of:
Types
EVLT devices, RFA devices, NTNT devices
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Research institute, Clinic, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- AngioDynamics Inc.
- Medtronic Plc
- Sciton Inc.
- Teleflex Inc.
- Venclose Inc.
Highlights of The Endovenous Ablation Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- EVLT devices
- RFA devices
- NTNT devices
- By Application:
- Hospital
- Research institute
- Clinic
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Endovenous Ablation Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Endovenous ablation devices are medical tools that use heat to destroy tissue. They are often used to treat conditions such as cancer, heart disease, and stroke.
Some of the major companies in the endovenous ablation devices market are AngioDynamics Inc., Medtronic Plc, Sciton Inc., Teleflex Inc., Venclose Inc..
The endovenous ablation devices market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Endovenous Ablation Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Endovenous Ablation Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Endovenous Ablation Devices Market - Supply Chain
4.5. Global Endovenous Ablation Devices Market Forecast
4.5.1. Endovenous Ablation Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Endovenous Ablation Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Endovenous Ablation Devices Market Absolute $ Opportunity
5. Global Endovenous Ablation Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Endovenous Ablation Devices Market Size and Volume Forecast by Type
5.3.1. EVLT devices
5.3.2. RFA devices
5.3.3. NTNT devices
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Endovenous Ablation Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Endovenous Ablation Devices Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Research institute
6.3.3. Clinic
6.3.4. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Endovenous Ablation Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Endovenous Ablation Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Endovenous Ablation Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Endovenous Ablation Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Endovenous Ablation Devices Demand Share Forecast, 2019-2026
9. North America Endovenous Ablation Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Endovenous Ablation Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Endovenous Ablation Devices Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Research institute
9.4.3. Clinic
9.4.4. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Endovenous Ablation Devices Market Size and Volume Forecast by Type
9.7.1. EVLT devices
9.7.2. RFA devices
9.7.3. NTNT devices
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Endovenous Ablation Devices Demand Share Forecast, 2019-2026
10. Latin America Endovenous Ablation Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Endovenous Ablation Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Endovenous Ablation Devices Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Research institute
10.4.3. Clinic
10.4.4. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Endovenous Ablation Devices Market Size and Volume Forecast by Type
10.7.1. EVLT devices
10.7.2. RFA devices
10.7.3. NTNT devices
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Endovenous Ablation Devices Demand Share Forecast, 2019-2026
11. Europe Endovenous Ablation Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Endovenous Ablation Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Endovenous Ablation Devices Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Research institute
11.4.3. Clinic
11.4.4. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Endovenous Ablation Devices Market Size and Volume Forecast by Type
11.7.1. EVLT devices
11.7.2. RFA devices
11.7.3. NTNT devices
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Endovenous Ablation Devices Demand Share, 2019-2026
12. Asia Pacific Endovenous Ablation Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Endovenous Ablation Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Endovenous Ablation Devices Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Research institute
12.4.3. Clinic
12.4.4. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Endovenous Ablation Devices Market Size and Volume Forecast by Type
12.7.1. EVLT devices
12.7.2. RFA devices
12.7.3. NTNT devices
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Endovenous Ablation Devices Demand Share, 2019-2026
13. Middle East & Africa Endovenous Ablation Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Endovenous Ablation Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Endovenous Ablation Devices Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Research institute
13.4.3. Clinic
13.4.4. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Endovenous Ablation Devices Market Size and Volume Forecast by Type
13.7.1. EVLT devices
13.7.2. RFA devices
13.7.3. NTNT devices
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Endovenous Ablation Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Endovenous Ablation Devices Market: Market Share Analysis
14.2. Endovenous Ablation Devices Distributors and Customers
14.3. Endovenous Ablation Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. AngioDynamics Inc.
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronic Plc
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Sciton Inc.
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Teleflex Inc.
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Venclose Inc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
